Latest Lead News

Goodman Group has announced an estimated ordinary dividend of AUD 0.15 per security for the six months ending June 30, 2025, with payment scheduled for August 26. Investors await further tax details due later in August.

Dexus reports a slight 0.4% increase in portfolio valuations driven by rental growth, alongside an 18-cent estimated distribution. Meanwhile, legal proceedings involving its APAC stake face delays, clouding future outcomes.

Biotron Limited has completed the initial safety phase of its lead Hepatitis B drug in animal studies, paving the way for efficacy testing in two distinct mouse models. This milestone marks a significant step forward in the company’s antiviral drug development program.

Bastion Mining has surpassed the critical 50.1% ownership threshold in Xanadu Mines, removing key conditions from its takeover bid and declaring the offer unconditional.

Adherium Limited is raising up to $4 million through a partially underwritten entitlement offer to expand its US digital health platform and recruit key personnel. The capital raise supports scaling patient onboarding and advancing its FDA-cleared smart inhaler technology.

Kip McGrath Education Centres announces exit from its unprofitable USA operations while reporting improved underlying EBITDA for FY25, alongside CEO transition costs and property lease provisions.

Fortifai Limited has successfully raised $2.3 million through an upsized share placement, aiming to bolster its AI Gaming Lab and technology partnerships. The capital injection will support ongoing operations and strategic growth initiatives.

Alliance Aviation Services has agreed to sell twelve General Electric CF34-10 engines to Beautech Power Systems for approximately USD40.2 million, aiming to reduce inventory and cut net debt without affecting profit guidance.

Aguia Resources’ latest NI 43-101 Technical Report on the Atocha Property in Colombia reveals significant high-grade gold and silver mineralization, supported by extensive drilling and sampling. The company proposes a CAD$600,000 exploration budget to advance this promising project.

High-Tech Metals Limited has appointed Tyler Formica to its board following a $2.5 million capital raise, while the company begins its search for a new CEO after not extending Warren Thorne's contract.

Radiopharm Theranostics has inked a clinical supply agreement with Cyclotek to support its Phase 1 trial of RAD 402, a novel radiotherapeutic targeting prostate cancer, set to commence in Australia in late 2025.

Polymetals Resources has completed a major refurbishment of its Endeavor processing plant and begun producing saleable silver-lead and zinc concentrates, marking a key milestone in its operational ramp-up.